Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations

ABSTRACT: The purpose of this study is to investigate the safety and efficacy of temsirolimus as a single drug, and of temsirolimus in combination with irinotecan in chemotherapy resistant patients with KRAS mutated colorectal cancer.

DISEASE(S): Colorectal Carcinoma,Metastatic Colorectal Cancer,Colorectal Neoplasms,Behandlingsresistente Patienter Med Metastaserende Colorectal Cancer Og Kras Mutationer

PROVIDER: 2066730 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR